Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: MarketLine (a Datamonitor Company)
$175.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Valeant Pharmaceuticals International responds to Allergan 's rejection of merger proposal


Tuesday, 13 May 2014 08:01am EDT 

Valeant Pharmaceuticals International Inc:Says that it has responded to Allergan Inc.'s rejection of Valeant's proposal to combine with Allergan for $48.30 in cash and 0.83 shares of Valeant common stock for each Allergan share.Receives Allergan's letter rejecting Valeant's offer on May 12. 

Company Quote

163.0
-0.13 -0.08%
21 Aug 2014